dx.doi.org/10.1038/leu.2015.220, hdl.handle.net/1765/81411
Leukemia
Department of Hematology

Dinmohamed, A.G, van Norden, Y, Visser, O, Posthuma, H.L.A, Huijgens, P.C, Sonneveld, P, … Jongen-Lavrencic, M. (2015). Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: Results from the Dutch population-based PHAROS MDS registry. Leukemia, 29(12), 2449–2451. doi:10.1038/leu.2015.220